8.56

3.38% 0.28

Treace Medical Concepts Inc (TMCI)

Overview News Price History Option Chain Financials Discussions Forecast

Treace Medical Concepts Inc stock is traded at $8.56, with a volume of 261.27K. It is up +3.38% in the last 24 hours and up +82.52% over the past month. Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.

Previous Close:

$8.28

Open:

$8.36

24h Volume:

261.27K

Relative Volume:

0.46

Market Cap:

$527.03M

Revenue:

$198.53M

Net Income/Loss:

$-63.68M

P/E Ratio:

-11.73

EPS:

-0.73

Net Cash Flow:

$-41.50M

1W Performance:

+7.27%

1M Performance:

+82.52%

6M Performance:

+65.89%

1Y Performance:

-3.06%

1-Day Range:

$8.36

$8.60

1-Week Range:

$7.735

$8.75

52-Week Range:

$3.92

$15.98

Treace Medical Concepts Inc Stock (TMCI) Company Profile

Name

Treace Medical Concepts Inc

Sector

Healthcare (1200)

Industry

Medical Devices (153)

Phone

(904) 373-5940

Address

100 PALMETTO PARK PLACE, PONTE VEDRA

Employee

227

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

TMCI's Discussions on Twitter

Compare TMCI with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TMCI Treace Medical Concepts Inc	8.56	527.03M	198.53M	-63.68M	-41.50M	-0.73
ABT Abbott Laboratories	118.95	208.18B	41.22B	5.77B	6.49B	2.94
SYK Stryker Corp	388.14	148.70B	21.97B	3.59B	3.21B	6.74
BSX Boston Scientific Corp	90.75	133.32B	15.91B	1.79B	1.89B	0.82
MDT Medtronic Plc	86.27	111.27B	33.00B	4.29B	5.50B	2.71
EW Edwards Lifesciences Corp	72.07	42.66B	6.60B	4.16B	490.10M	2.34

Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-16-24	Downgrade	UBS	Buy → Neutral
May-08-24	Downgrade	BTIG Research	Buy → Neutral
May-08-24	Downgrade	JP Morgan	Overweight → Neutral
May-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
May-08-24	Downgrade	Stifel	Buy → Hold
May-08-24	Downgrade	Truist	Buy → Hold
Sep-29-23	Initiated	UBS	Buy
May-01-23	Initiated	Truist	Buy
Apr-11-23	Initiated	Stephens	Equal-Weight
May-12-22	Initiated	BTIG Research	Buy
Jan-07-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
May-18-21	Initiated	JP Morgan	Overweight
May-18-21	Initiated	Morgan Stanley	Equal-Weight
May-18-21	Initiated	SVB Leerink	Outperform
May-18-21	Initiated	Stifel	Buy

View All

Treace Medical Concepts Inc Stock (TMCI) Latest News

Nov 27, 2024

Brokerages Set Treace Medical Concepts, Inc. (NASDAQ:TMCI) Target Price at $7.40 - Defense World

Nov 27, 2024

Nov 26, 2024

TMCI Investors Have Opportunity to Join Treace Medical Concepts, Inc. Fraud Investigation with the Schall Law Firm - GuruFocus.com

Nov 26, 2024

Nov 24, 2024

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Nov 24, 2024

Nov 18, 2024

Treace Announces Participation at Stifel 2024 Healthcare Conference - The Manila Times

Nov 18, 2024

Treace Medical CEO to Present at Stifel 2024 Healthcare Conference | TMCI Stock News - StockTitan

Nov 18, 2024

Nov 15, 2024

Treace Medical Concepts, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 15, 2024

Nov 14, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Treace Medi - GuruFocus.com

Nov 14, 2024

Nov 09, 2024

Treace Medical Concepts Reports Strong Q3 2024 Growth - TipRanks

Nov 09, 2024

Morgan Stanley's Strategic Reduction in Treace Medical Concepts Inc. - GuruFocus.com

Nov 09, 2024

Nov 07, 2024

Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 07, 2024

Nov 06, 2024

Earnings call: Treace Medical Concepts reported an 11% increase in third-quarter revenue - Investing.com India

Nov 06, 2024

U.S. Stock market: SONN(+86.46%), DataChat(+50.28%), Cytek Biosciences(+30.51%) among the top gainers during early trading - Business Upturn

Nov 06, 2024

Treace Medical (TMCI) Experiences Stock Boost After Reporting Strong Results - Stocks Telegraph

Nov 06, 2024